- About Us
- Nano-Social Network
- Nano Consulting
- My Account
October 8th, 2007
A swaggering Texas investor with a famous name wants Big Pharma to pick up the tab for the International Space Station when NASA eases off.
Thomas Pickens III thinks the pharmaceutical industry and the space station need each other.
Drug discovery is an arduous and extremely expensive project. But in space, molecules do miraculous things. Disease-causing proteins crystallize so well -- growing larger and clearer -- that finding a drug to stop the protein's damaging activities could happen months, if not years, faster.
Scientists have known for decades that some science works better in space -- but it hasn't been easy to get experiments up there. Now, with NASA planning to reduce its $2.6 billion annual investment beginning in 2015, the agency is throwing the space station open for private enterprise. And the Texas financial scion and multimillionaire is ready to transform space science with an injection of capitalism.
|Related News Press|
New active filaments mimic biology to transport nano-cargo: A new design for a fully biocompatible motility engine transports colloidal particles faster than diffusion with active filaments January 11th, 2017
Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017
Strength of hair inspires new materials for body armor January 18th, 2017
Self-assembling particles brighten future of LED lighting January 18th, 2017
Nanoparticle exposure can awaken dormant viruses in the lungs January 17th, 2017
Infrared instrumentation leader secures exclusive use of Vantablack coating December 5th, 2016
New records set up with 'Screws of Light' November 20th, 2016
Keep it Clean: Leti and French Partners to Test ‘Smart’ Antibacterial Surfaces in Space: Matiss Experiment Designed to Measure Most Effective Material for Cleaning International Space Station and Is Expected to Provide Earth-bound Applications November 15th, 2016